Last reviewed · How we verify
testosterone anastrozole
At a glance
| Generic name | testosterone anastrozole |
|---|---|
| Also known as | testosterone, anastrozole |
| Sponsor | Havah Therapeutics Pty Ltd |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment (PHASE2)
- The Role of Estrogen and Testosterone in Determining Brain Blood Flow and Metabolic Regulation in Humans (NA)
- Brain Blood Flow Responses to Stress: Sex Differences (PHASE4)
- Cardiovascular Outcomes of Low Testosterone (NA)
- Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter Syndrome (PHASE3)
- Regulation of Cortisol Metabolism and Fat Patterning (NA)
- Testosterone Implants and the Incidence of Breast Cancer
- Study of Exposure to Substances Prohibited by the World Anti-Doping Agency in Healthy Volunteers. (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- testosterone anastrozole CI brief — competitive landscape report
- testosterone anastrozole updates RSS · CI watch RSS
- Havah Therapeutics Pty Ltd portfolio CI